ifosfamide has been researched along with sepharose in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harimoto, N; Hashimoto, I; Ijima, H; Kawabata, K; Kawakami, K; Mu, C; Sakai, S; Salmons, B; Tanaka, S | 1 |
Hashimoto, I; Kawakami, K; Sakai, S; Salmons, B; Tanaka, S | 1 |
2 other study(ies) available for ifosfamide and sepharose
Article | Year |
---|---|
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biophysics; Cats; Cell Line; Cell Size; Cell Survival; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Humans; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxazines; Particle Size; Sepharose; Temperature; Time Factors | 2005 |
Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
Topics: Animals; Antineoplastic Agents, Alkylating; Capsules; Cell Transplantation; Cell- and Tissue-Based Therapy; Cells, Cultured; Combined Modality Therapy; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Sepharose; Skin Neoplasms; Xenograft Model Antitumor Assays | 2009 |